antibodi
induc
receptorbind
domain
spike
protein
sarscov
crossneutr
novel
human
coronaviru
hcovemc
recent
chan
et
al
report
journal
convalesc
sar
patient
sera
may
contain
crossreact
antibodi
emerg
novel
human
coronaviru
hcovemc
detect
immunofluoresc
neutral
antibodi
test
sar
coronaviru
sarscov
caus
agent
sar
use
angiotensinconvert
enzym
cellular
receptor
bind
target
cell
acid
fragment
residu
subunit
vial
spike
protein
identifi
receptorbind
domain
rbd
recent
emerg
hcovemc
caus
peopl
infect
includ
death
http
rais
seriou
concern
potenti
pandem
unlik
sarscov
hcovemc
use
differ
receptor
dipeptidyl
bind
entri
target
cell
predict
acid
fragment
residu
hcovemc
region
contain
viral
rbd
previous
report
rbd
sarscov
protein
contain
multipl
neutral
epitop
induc
potent
neutral
antibodi
protect
sarscov
infect
anim
model
thu
neutral
antibodi
target
protein
particularli
rbd
play
import
role
inhibit
viral
infect
sinc
sarscov
hcovemc
genet
belong
genu
betacoronaviru
thu
specul
antibodi
induc
rbd
sarscov
may
crossreact
crossneutr
activ
hcovemc
prove
first
test
reactiv
seri
sarscov
rbdspecif
monoclon
antibodi
mab
recombin
protein
contain
residu
put
rbd
residu
hcovemc
found
mab
recogn
conform
conf
ievi
group
aee
linear
epitop
rbd
sarscov
low
bind
rbd
protein
hcovemc
concentr
high
mgml
strong
bind
recombin
rbd
protein
sarscov
test
concentr
mgml
fig
result
suggest
antibodi
induc
rbd
sarscov
protein
crossreact
rbd
protein
hcovemc
next
detect
neutral
activ
repres
sarscov
srbdspecif
neutral
mab
hcovemc
infect
cell
express
receptor
hcovemc
sarscov
infect
cell
express
receptor
sarscov
use
establish
pseudoviru
neutral
assay
shown
fig
except
mab
conf
lower
neutral
mab
includ
recogn
conform
epitop
conf
iievi
group
b
rbd
sarscov
neutral
sarscov
pseudoviru
concentr
mgml
respect
howev
mab
could
neutral
hcovemc
pseudoviru
concentr
high
mgml
suggest
sarscov
rbdspecif
neutral
mab
low
crossneutr
hcovemc
confirm
conclus
perform
anoth
experi
test
neutral
activ
antibodi
sera
sarscov
srbd
proteinvaccin
mice
shown
fig
none
test
sera
neutral
hcovemc
pseudoviru
dilut
could
potent
neutral
sarscov
pseudoviru
infect
cell
dilut
result
confirm
antibodi
induc
rbd
sarscov
protein
crossneutr
hcovemc
infect
therefor
epitop
sarscov
protein
elicit
antibodi
crossreact
crossneutr
activ
hcovemc
may
locat
rbd
subunit
sarscov
bioinformat
analysi
protein
sarscov
hcovemc
chan
et
al
found
immunogen
region
hcovemc
emcii
sarscov
sarsi
overlap
heptad
repeat
region
domain
hcovemc
sarscov
sarscov
harbor
epitop
broadli
neutral
antibodi
case
sarscov
thu
believ
epitop
locat
region
may
respons
induc
crossneutr
antibodi
hcovemc
sarscov
howev
experi
prove
hypothesi
warrant
figur
crossreact
crossneutr
activ
sarscov
srbdspecif
antibodi
hcovemc
reactiv
sarscov
srbdspecif
mab
rbd
andor
protein
hcovemc
sarscov
detect
elisa
conf
ievi
group
aee
linear
mab
repres
mab
target
conform
linear
epitop
rbd
sarscov
protein
respect
mab
specif
hemagglutinin
ha
influenza
viru
use
neg
control
data
present
mean
ae
standard
deviat
sd
duplic
well
neutral
sarscov
srbdspecif
mab
b
sarscov
srbd
proteinvaccin
mous
antisera
c
hcovemc
sarscov
infect
pseudoviru
neutral
assay
data
present
mean
percentag
neutral
ae
sd
duplic
well
repeat
lumbar
punctur
adult
pneumococc
mening
observ
studi
behalf
british
infect
societi
heyderman
recent
publish
second
edit
guidelin
manag
bacteri
mening
adult
although
prompt
diagnosi
emphas
relev
repeat
lumbar
punctur
rlp
still
unclear
base
old
studi
involv
children
aim
studi
evalu
treatment
modif
rlp
retrospect
analys
medic
record
patient
confirm
pneumococc
mening
hospit
icu
bichat
e
claud
bernard
bed
univers
hospit
januari
februari
polici
admit
patient
confirm
pneumococc
mening
first
h
local
ethic
committe
approv
studi
waiv
individu
consent
collect
characterist
patient
admiss
icu
time
rlp
day
case
rlp
data
collect
diagnost
lumbar
punctur
dlp
first
rlp
reason
perform
rlp
either
persist
coma
inabl
evalu
conscious
sedat
patient
regist
glasgow
coma
scale
gc
score
day
use
gc
score
admiss
unless
indic
patient
coma
regist
gc
confirm
brain
death
regist
gc
surgic
procedur
comput
tomographi
ct
abnorm
collect
minimum
inhibitori
concentr
mic
penicillin
amoxicillin
cefotaxim
record
suscept
penicillin
defin
sensit
mic
mgl
intermedi
mic
mgl
resist
mic
mgl
first
line
recommend
regimen
includ
third
gener
cephalosporin
adjunct
vancomycin
case
suspect
penicillin
resist
strain
sever
case
septic
shock
deep
coma
